Neutral endopeptidase 24.11: Its physiologic and possibly pathophysiologic role in inflammation with special effect on respiratory inflammation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 11, 1998, Pages 1023-1042

  Koehne, P ^a,c   Schaper C ^a   Graf, K ^b   Kunkel, G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Airways; Asthma; Neurogenic inflammation; Neutral endopeptidase 24.11; Nurokinin A; Rhinitis; Substance P; Vasoactive intestinal peptide

Indexed keywords

GLUCOCORTICOID; MEMBRANE METALLOENDOPEPTIDASE; NEUROKININ A; NEUROPEPTIDE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ASTHMA; BRONCHOSPASM; BRONCHUS SECRETION; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME SUBSTRATE; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR BIOLOGY; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINITIS; TISSUE DISTRIBUTION;

EID: 0031792963     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03812.x     Document Type: Review

References (248)

1. Kerr MA, Kenny AJ. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J 1974;137:477-88.
2. Cossman J, Neckers LM, Leonard WJ, Greene WC. Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen. J Exp Med 1983;157:1064-9.
3. Letarte M, Vera S, Tran R, et al. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J Exp Med 1988;168:1247-53.
4. Shipp MA, Vijayaraghavan J, Schmidt EV, et al. Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis. Proc Natl Acad Sci U S A 1989;86:297-301.
5. Jongeneel CV, Quackenbush EJ, Ronco P, Verroust P, Carrel S, Letarte M. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity. J Clin Invest 1989;83:713-17.
6. Stewart JR, Kenny AJ. Proteins of the kidney microvillar membrane. Biosynthesis of endopeptidase-24.11, dipeptidylpeptidase IV, and aminopeptidase A and N in pig kidney slices. Biochem J 1984;224:549-58.
7. Lorkowski G, Zijderhand-Bleekemolen JE, Erdös EG, von Figura K, Hasilik A. Neutral endopeptidase-24.11 (enkephalinase). Biosynthesis and localization in human fibroblasts. Biochem J 1987;248:345-50.
8. Maroux S. Structural and topological aspects. In: Kenny AJ, Turner AJ, editors. Mammalian ectoenzymes. Amsterdam: Elsevier Science, 1987:15-45.
9. Tam LT, Engelbrecht S, Talent JM, Gracy RW, Erdös EG. The importance of disulfide bridges in human endopeptidase (enkephalinase) after proteolytic cleavage. Biochem Biophys Res Commun 1985;133:1182-92.
10. Malfroy B, Schofield PR, Kuang WJ, Seeburg PH, Mason AJ, Henzel WJ. Molecular cloning and amino acid sequence of rat enkephalinase. Biochem Biophys Res Commun 1987;144:59-66.
11. Devault A, Lazure C, Nault C, et al. Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J 1987;6:1317-22.
12. Malfroy B, Kuang WJ, Seeburg PH, Mason AJ, Schofield PR. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett 1988; 229:206-10.
13. Fulcher IS, Chaplin MF, Kenny AJ. Endopeptidase 24.11 purified from frog intestine is differently glycosylated from that in kidney. Biochem J 1983;215:317-23.
14. Lecavallier H, Crine P, Malo C. Presence of endopeptidase 24.11 during the ontogeny of the small intestine in different species. Biol Neonate 1989;56:342-50.
15. Benchetrit T, Bissery V, Mornon JP, Devault A, Crine P, Roques BP. Primary structure homologies between two Zn-metallopeptidases, the neutral endopeptidase 24.11 "enkephalinase" and the thermolysin, through clustering. Biochemistry 1988;27:592-7.
16. Soubrier F, Alhene-Gelas F, Hubert C, et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A 1988;85:9386-90.
17. Jongeneel CV, Bouvier J, Bairoch A. A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett 1989;242:211-14.
18. Hélène A, Beaumont A, Roques BP. Functional residues at the active site of aminopeptidase N. Eur J Biochem 1991;196:385-93.
19. Erdös EG, Skidgel RA. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989;3:145-51.
20. Vallee BL, Auld DS. Zinc coordinalion function and structure of zinc enzymes and other proteins. Biochemistry 1990;29:5647-59.
21. Devault A, Sales N, Nault C, et al. Exploration of the catalytic site of endopeptidase 24.11 by site-directed mutagenesis. Histidine residues 583 and 587 are essential for catalysis. FEBS Lett 1988;231:54-8.
22. Le Moual H, Devault A, Roques BP, Crine P, Boileau G. Identification of glutamic acid 646 as a zinc-coordinating residue in endopeptidase 24.11. J Biol Chem 1991;266: 15670-4.
23. Devault A, Nault C, Zollinger M, et al. Expression of neutral endopeptidase (enkephalinase) in heterologous cos-1 cells: active site. J Biol Chem 1988;263:4033-40.
24. 747 are involved in substrate binding to neutral endopeptidase (EC. 3.4.24.11). J Biol Chem 1991;266:214-20.
25. Bateman RC Jr, Jackson D, Slaughter CA, et al. Identification of the active-site origin in rat neutral endopeptidase 24.11 (enkephalinase) as arginine 102 and analysis of a glutamine 102 mutant. J Biol Chem 1989;264:6151-7.
26. Beaumont A, Barbe B, Le Moual H, et al. Charge polarity reversal inverses the specificity of neutral endopeptidase 24.11. J Biol Chem 1992;267:2138-41.
27. Vijayaraghavan J, Kim Y-A, Jackson D, Orlowski M, Hersh LB. Use of site-directed mutagenesis to identify valine-573 in the S′ 1 binding site of rat neutral endopeptidase 24.11 (enkephalinase). Biochemistry 1990; 29:8052-6.
28. Bateman RC, Young AE, Slaughter CA, Hersh LB. N-bromo-acetyl-D-leucylglycine: an affinity label for neutral endopeptidase 24.11. J Biol Chem 1990;265:8365-8.
29. Kim YA, Shriver B, Hersh LB. Mutational analysis reveals only one catalytic histidine in neutral endopeptidase ("enkephalinase"). Biochem Biophys Res Commun 1992;184:883-7.
30. D'Adamio L, Shipp MA, Masteller EL, Reinherz EI. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5′ untranslated regions. Proc Natl Acad Sci U S A 1989;86:7103-7.
31. Le Bien TW, McCormack RT. The common acute lymphoblastic leukemia antigen (CD10) - emancipation from a functional enigma. Blood 1989;73:625-35.
32. Tran-Paterson R, Willard HF, Letarte M. The common acute lymphoblastic leukemia antigen (neutral endopeptidase 3.4.24.11) gene is located on human chromosome 3. Cancer Genet Cytogenet 1989;42:129-34.
33. Matthews BW. Structural basis of the action of thermolysin and related zinc peptidases. Accounts Chem Res 1988; 21:333-40.
34. Roques BP, Noble F, Dauge V, Fournié-Zaluski MC, Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993;45:87-146.
35. Erdös EG, Skidgel RA. Human neutral endopeptidase 24.11 (NEP, enkephalinase); function, distribution and release. Adv Exp Med Biol 1988;240:13-21.
36. Hersh LB, Morihara K. Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin. J Biol Chem 1986;261:6433-7.
37. Kerr MA, Kenny AJ. The molecular weight and properties of a neutral metallo-endopeptidase from rabbit kidney brush border. Biochem J 1974;137:489-95.
38. Orlowski M, Wilk S. Purification and specificity of a membrane bound metalloendopeptidase from bovine pituitaries. Biochemistry 1981;20:4942-50.
39. Katayama M, Nadel JA, Bunnett NW, Di Maria GU, Haxhiu M, Borson DB. Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides 1991;12:563-7.
40. Stephenson SL, Kenny AJ. The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11. Biochem J 1987;243:183-7.
41. Pierart ME, Najidovski T, Appelboom TE, Deschodt-Lanckman MM. Effect of human endopeptidase 24.11 ("enkephalinase") on IL-1-induced thymocyte proliferation activity. J Immunol 1988;140:3808-11.
42. Erdös EG, Skidgel RA. Renal metabolism of angiotensin I and angiotensin II. Kidney Int 1990;38 Suppl 30:S24-7.
43. Gafford JT, Skidgel RA, Erdös EG, Hersh LB. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 1983;22:3265-71.
44. Vogt-Schaden M, Gagelmann M, Hock D, Herbst F, Forssmann WG. Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranes. Biochem Biophys Res Commun 1989;161:1177-83.
45. Connelly JC, Skidgel RA, Schulz WW, Johnson AR, Erdös EG. Neutral endopeptidase-24.11 in human neutrophils: cleavage of chemotactic peptide. Proc Natl Acad Sci U S A 1985;82:8737-41.
46. 11 bond by synaptic endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase. J Neurochem 1984;43:1295-1301.
47. Graf L, Paldi A, Patthy A. Action of neutral metalloendopeptidase ("enkephalinase") on B-endorphin. Neuropeptides 1985;6:13-19.
48. Matsas R, Kenny AJ, Turner AJ. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem J 1984;223:433-40.
49. Power DM, Bunnett NW, Turner AJ, Dimaline R. Degradation of endogenous heptadecapeptide gastrin by endopeptidase 24.11 in the pig. Am J Physiol 1987;253 (Gastrointest Liver Physiol 16):G33-9.
50. Bunnett NW, Debas HT, Turner AJ, Kobayashi R, Walsh JH. Metabolism of gastrin and cholecystokinin by endopeptidase 24.11 from pig stomach. Am J Physiol 1988;255:G676-84.
51. Mumford RA, Pierzchala PA, Strauss AW, Zimmerman M. Purification of a membrane-bound metalloendopeptidase from porcine kidney that degrades peptide hormones. Proc Natl Acad Sci U S A 1981;78:6623-7.
52. Turner AJ. Endopeptidase-24.11 and neuropeptide metabolism. In: Turner AJ, editor. Neuropeptides and their peptidases. Amsterdam: Ellis-Horwood, 1987:183-201.
53. Molineaux CJ, Lasdun A, Michaud C, Orlowski M. Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo. J Neurochem 1988;51:624-33.
54. Leblanc R, L'Heritier A, Kordon C, et al. Characterization of a neutral endopeptidase localized in the mitochondrial matrix of rat anterior pituitary tissue with GnRH as a substrate. Neuroendocrinology 1984;38:476-83.
55. Stephenson SL, Kenny AJ. Metabolism of neuropeptides: hydrolysis of the angiotensins, bradykinin, substance P and oxytocin by pig kidney microvillar membranes. Biochem J 1987;241:237-47.
56. Johnson AR, Skidgel RA, Gafford JT, Erdös EG. Enzymes in placental microvilli: angiotensin I converting enzyme, angiotensinase A, carboxypeptidase, and neutral endopeptidase ("enkephalinase"). Peptides 1984;5:789-96.
57. Sokolovsky M, Galron R, Kloog Y, et al. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc Natl Acad Sci U S A 1990;87:4702-6.
58. Malfroy B, Schwartz JC. Properties of enkephalinase from rat kidney: comparison of dipeptidyl-carboxypeptidase and endopeptidase activities. Biochem Biophys Res Commun 1982;106:276-85.
59. Fournié-Zaluski MC, Perdrisot R, Gacel G, Swerts JP, Roques BP, Schwartz JC. Inhibitory potency of various peptides on enkephalinase activity from mouse striatum. Biochem Biophys Res Commun 1979;91:130-5.
60. Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978;276:523-6.
61. Hudgin RL, Charleson SE, Zimmerman M, Mumford R, Wood PL. Enkephalinase: selective peptide inhibitor. Life Sci 1981;29:2593-2601.
62. De La Baume S, Patey G, Schwartz JC. Subcellular distribution of enkephalin-dipeptidyl carboxypeptidase (enkephalinase) in rat brain. Neuroscience 1981;6:315-21.
63. Turner AJ, Hooper NM, Kenny AJ. Metabolism of neuropeptides. In: Kenny AJ, Turner AJ, editors. Mammalian ectoenzymes. Amsterdam: Elsevier Science, 1987: 211-48.
64. Erdös EG, Johnson AR, Boyden NT. Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase. Biochem Pharmacol 1978;27: 843-8.
65. Skidgel RA, Erdös EG. Biochemistry of angiotensin converting enzyme. In: Robertson JIS, Nicholls MG, editors. The renin angiotensin system. London: Gower, 1993:10.1-10.10.
66. Roques BP, Fournié-Zaluski MC, Soroca E, et al. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 1980;288:286-8.
67. Gorman CM, Gies D, Schofield PR, Kado-Fong H, Malfroy B. Expression of enzymatically active enkephalinase (neutral endopeptidase) in mammalian cells. J Cell Biochem 1989;39:277-84.
68. Mullol J, Chowdhury B, White M, et al. Endothelin in human nasal mucosa. Am J Respir Cell Mol Biol 1993;8:393-402.
69. Modin A, Pernow J, Lundberg JM. Phosphoramidon inhibits the vasoconstrictor effects evoked by pig endothelin-1 but not the elevation of plasma endothelin-1 in vivo. Life Sci 1991;49:1619-25.
70. Di Maria GU, Katayama M, Borson DB, Nadel JA. Neutral endopeptidase modulates endothelin-1 induced airway smooth muscle contraction in guinea-pig trachea. Regul Pept 1992;39:137-45.
71. Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 1990;265:14150-5.
72. Saria A, Martling CR, Yan Z, Theodorsson-Norheim E, Gamse R, Lundberg JM. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis 1988;137: 1330-5.
73. Yong T, Gao XP, Koizumi S, et al. Role of peptidases in bradykinin-induced increase in vascular permeability in vivo. Circ Res 1992;70:952-9.
74. Barnes PJ. Bradykinin and asthma. Thorax 1992;47: 979-83.
75. Ura N, Carretero OA, Erdös EG. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int 1987;32:507-13.
76. Helke CJ, Krause JE, Mantyh PW, Couture R, Bannon MJ. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J 1990;4:1606-15.
77. Martling CR, Theodorsson-Norheim E, Lundberg JM. Occurrence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways. Life Sci 1987;40:1633-43.
78. Piedimonte G, McDonald DM, Nadel JA. Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea. J Clin Invest 1990;86:1409-15.
79. Katayama M, Nadel JA, Piedimonte G, McDonald DM. Peptidase inhibitors reverse steroid-induced suppression of neutrophil adhesion in rat tracheal blood vessels. Am J Physiol 1993;264:L316-22.
80. Kohrogi H, Graf PD, Sekizawa K, Borson DB, Nadel JA. Neutral endopeptidase inhibitors potentiate substance P-and capsaicin-induced cough in awake guinea-pigs. J Clin Invest 1988;82:2063-8.
81. Rogers DF, Aursudkij B, Barnes PJ. Effects of tachykinins son mucus secretion in human bronchi in vitro. Eur J Pharmacol 1989;174:283-6.
82. Kroegel C, Giembycz MA, Barnes PJ. Characterization of eosinophil cell activation by peptides. Differential effects of substance P, mellitin, and f-met-leu-phe. J Immunol 1990;145:2581-7.
83. 1 receptors. Br J Pharmacol 1990;100:417-20.
84. McGillis JP, Organist ML, Payan DG. Substance P and immunoregulation. Fed Proc 1987;46:196-9.
85. Lotz M, Vaughan J, Carson D. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218-21.
86. Harrison NK, Dawes KE, Barnes PJ, Laurent GJ, Chung KF. Effects of neurokinin A, substance P and vasoactive intestinal peptide on human lung fibroblast proliferation and chemotaxis. Am Rev Respir Dis 1992; 145:A681.
87. Calvo CF, Chavanel G, Senik A. Substance P enhances IL-2 expression in activated human T cells. J Immunol 1992;148:3498-3504.
88. Stjarne P, Lacroix JS, Anggard A, Lundberg JM. Compartment analysis of vascular effects of neuropeptides and capsaicin in the pig nasal mucosa. Acta Physiol Scand 1991;141:335-42.
89. Skidgel RA, Engelbrecht S, Johnson AR, Erdös EG. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 1984;5: 769-76.
90. Webber SE. Receptors mediating the effects of substance P and neurokinin A on mucus secretion and smooth muscle tone of the ferret trachea: potentialion by an enkephalinase inhibitor. Br J Pharmacol 1989;98:1197-1206.
91. Salonen RO, Webber SE, Widdicombe JG. Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo. Br J Pharmacol 1988;95:1262-70.
92. Hooper NM, Kenny AJ, Turner AJ. The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin converting enzyme). Biochem J 1985;231: 357-61.
93. Webber SE. The effects of peptide histidine isoleucine and neuropeptide Y on mucus volume output from the ferret trachea. Br J Pharmacol 1988;95:49-54.
94. Hakanson R, Wahlestedt C. Neuropeptide Y acts via prejunctional (Y2) and postjunctional (Y1) receptors. Neuroscience 1987;22:S679.
95. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ. Neuropeptide Y is a vasoconstrictor in human nasal mucosa. J Appl Physiol 1992;73:1867-72.
96. Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol Sci 1990;11:185-9.
97. 2-adrenoceptors and opiate receptors. Eur J Pharmacol 1989;163:15-23.
98. Russell JA, Simons EJ. Modulation of cholinergic neurotransmission in airways by enkephalin. J Appl Physiol 1985;58:853-8.
99. Kuo HP, Rhode JAL, Barnes PJ, Rogers DF. Opioid inhibition of neurogenic goblet cell secretion: differential effects on cigarette smoke, capsaicin and electrically induced responses in guinea-pig trachea in vitro. Br J Pharmacol 1992;105:361-6.
100. Belvisi MG, Rogers DF, Barnes PJ. Neurogenic plasma extravasation: inhibition by morphine in guinea-pig airways in vivo. J Appl Physiol 1989;66:268-72.
101. Shipp MA, Stefano GB, D'Adamio L, et al. Down-regulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature 1990;347:394-6.
102. 8. J Neurochem 1987;48:284-92.
103. Webber SE, Lim J, Widdicombe J. The effects of calcitonin gene-related peptide on submucosal gland secretion and epithelial albumin transport in ferret trachea in vitro. Br J Pharmacol 1989;120:79-84.
104. McCormack DG, Mak JCW, Coupe MO, Barnes PJ. Calcitonin gene-related peptide vasodilation of human pulmonary vessels: receptor mapping and functional studies. J Appl Physiol 1989;67:1265-70.
105. Matran R, Alving K, Martling CR, Lacroix JS, Lundberg JM. Effects of neuropeptides and capsaicin on tracheobronchial blood flow of the pig. Acta Physiol Scand 1989;135:335-42.
106. Palmer JB, Cuss FS, Mulderry PK, et al. Calcitonin gene-related peptide is localized to human airway nerves and potently constricts human airway smooth muscle. Br J Pharmacol 1987;91:95-101.
107. Umeda Y, Arisawa H. Characterization of the calcitonin gene-related peptide receptor in mouse T-lymphocytes. Neuropeptides 1989;14:237-43.
108. Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989;143:45-9.
109. Gamse R, Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol 1985;114:61-6.
110. Hokfelt T. Neuropeptides in perspective: the last ten years. Neuron 1991;7:867-79.
111. Brokaw JJ, White GW. Calcilonin gene-related peptide potentiates substance P-induced plasma extravasation in the rat trachea. Lung 1992;170:85-93.
112. Stretton CD, Barnes PJ. Cholecystokinin-octapeptide constricts guinea-pig and human airways. Br J Pharmacol 1989;97:675-82.
113. Baraniuk JN, Lundgren JD, Okayama M, et al. Vasoactive intestinal peptide (VIP) in human nasal mucosa. J Clin Invest 1990;86:825-31.
114. Coles S, Said S, Reid L. Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro. Am Rev Respir Dis 1981;124: 531-6.
115. Nathanson I, Widdicombe JH, Barnes PJ. Effect of vasoactive intestinal peptide on ion transport across dog tracheal epithelium. J Appl Physiol 1988;55:1844-8.
116. Undem B, Dick E, Buckner C. Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung. Eur J Pharmacol 1983;88: 247-50.
117. Sekizawa K, Tamaoki J, Graf PD, Nadel JA. Modulation of cholinergic transmission by vasoactice intestinal peptide in ferret trachea. J Appl Physiol 1988;69:2433-7.
118. Greenberg B, Rhoden K, Barnes PJ. Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries. Blood Vessels 1987;24:45-50.
119. Saga T, Said SI. Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma. Trans Assoc Am Physicians 1984;97: 304-10.
120. Cheng PPJ, Sreedharan SP, Kishiyama JL, Goetzl EJ. The SKW 6.4 line of human B-lymphocytes specifically binds and responds to vasoactive intestinal peptide. Immunology 1993;79:64-8.
121. Hassner A, Lau MS, Goetzl EJ, Adelman DC. Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide (VIP). J Allergy Clin Immunol 1993;92:891-901.
122. Mathew RC, Cook GA, Blum AM, Metwali A, Felman R, Weinstock JV. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine Schistosoma mansoni infection. J Immunol 1992;148:3572-7.
123. Maruno K, Said SI. Inhibition of human airway smooth muscle cell proliferation by vasoactive intestinal peptide (VIP). Am Rev Respir Dis 1993;147:A253.
124. Goetzl EJ, Sreedharan SP, Turck CW, Bridenbaugh R, Malfroy B. Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11). Biochem Biophys Res Commun 1989;158:850-4.
125. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER. Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 1988;59:5-24.
126. Willey JC, Lechner JF, Harris CC. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp Cell Res 1984;153:245-8.
127. Rozengurt E, Sinnett-Smith J. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc Natl Acad Sci U S A 1983;80:2936-40.
128. Aguayo SM, King TE Jr, Waldron JA Jr, Sherritt KM, Kane MA, Miller YE. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 1990;86:838-44.
129. Sunday ME, Hua J, Torday JS, Reyes B, Shipp MA. CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest 1992;90: 2517-25.
130. Baraniuk JN, Lundgren JD, Goff J, et al. Gastrin releasing peptide (GRP) in human nasal mucosa. J Clin Invest 1990;85:998-1005.
131. Salonen RO, Webber SE, Widdicombe JG. Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo. Br J Pharmacol 1988;95:1262-70.
132. Belvisi MG, Stretton CD, Barnes PJ. Bombesin-induced bronchoconstriction in the guinea-pig: mode of action. J Pharmacol Exp Ther 1991;258:36-41.
133. Shipp MA, Tarr GE, Chen CY, et al. CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci U S A 1991;88:10662-6.
134. Bunnett NW, Kobayashi R, Orloff MS, Reeve JR, Turner AJ, Walsh JH. Catabolism of gastrin releasing peptide and substance P by gastric membrane-bound peptidases. Peptides 1985;6:277-83.
135. Werb Z, Clark EJ. Phorbol diesters regulate expression of the membrane neutral metalloendopeptidase (EC 3.4.24.11) in rabbit synovial fibroblasts and mammary epithelial cells. J Biol Chem 1989;264:9111-13.
136. Erdös EG, Wagner B, Harbury CB, Painter RG, Skidgel RA, Fa XG. Down-regulation and inactivation of neutral endopeptidase 24.11 (enkephalinase) in human neutrophils. J Biol Chem 1989;264:14519-23.
137. Borson DB, Gruenert DC. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol 1991;260(Lung Cell Mol Physiol 4):L83-9.
138. Yamamoto KR. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 1985;19:209-52.
139. Lang Z, Murlas CG. Neutral endopeptidase of a human airway epithelial cell line recovers after hypochlorous acid exposure: dexamethasone accelerates this by stimulating neutral endopeptidase mRNA synthesis. Am J Respir Cell Mol Biol 1992;7:300-6.
140. Casey ML, Smith JW, Nagai K, Hersh LB, MacDonald PC. Progesterone-regulated cyclic modulation of membrane metallopeptidase (enkephalinase) in human endometrium. J Biol Chem 1991;266:23041-7.
141. Dickinson KEJ, Tymiak AA, Cohen RB, Liu ECK, Webb ML, Hedberg A. Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase. Biochem Biophys Res Commun 1991;176:423-30.
142. Proud D, Subauste M, Ward P. Glucocorticoids do not alter peptidase expression on a human bronchial epithelial cell line. Am J Respir Cell Mol Biol 1994;11:57-66.
143. Werfel T, Sonntag G, Weber MH, Götze O. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fcγ-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991;147:3909-14.
144. Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977;59:879-88.
145. Oppermann M, Haubitz M, Quentin E, Götze O. Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C5 and factor B. Klin Wochenschr 1988;66:857-64.
146. Kondepudi A, Johnson A. Cytokines increase neutral endopeptidase activity in lung fibroblasts. Am J Respir Cell Mol Biol 1993;8:43-9.
147. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL. CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 1991;78: 1834-41.
148. Rosenfeld C, Goutner A, Choquet C, Venuat AM, Kayibauda M, Picot JL. Phenotypic characterization of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 1977;267:841-3.
149. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RF. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965;18:522-9.
150. Milhiet PE, Beaumont A, Garbay-Jaureguiberry C, Roques BP. Increase of neutral endopeptidase-24.11 with cellular density and enzyme modulation with an inhibitor on human REH6 cell line. Biochem Pharmacol 1992;43:1711-15.
151. Dussaule JC, Stefanski A, Béa ML, Ronco P, Ardaillou R. Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex. Am J Physiol 1993;264(Ren Fluid Electrolyte Physiol 33):F45-52.
152. Zhang M, Niehus J, Schnellbacher T, et al. ELISA for the neuropeptide degrading endopeptidase 3.4.24.11 in human serum and leukocytes. Peptides 1994;15:843-8.
153. Graf K, Koehne P, Gräfe M, Zhang M, Auch-Schwelk W, Fleck E. Regulation and differential expression of neutral endopeptidase in human endothelial cells. Hypertension 1995;26:230-5.
154. Graf K, Kunkel K, Zhang M, et al. Activation of adenylate cyclase and phosphodiesterase inhibition enhance neutral endopeptidase activity in human endothelial cells. Peptides 1995;17:1273-8.
155. Jalal F, Lemay G, Zollinger M, Berteloot A, Boileau G, Crine P. Neutral endopeptidase, a major brush border protein of the kidney proximal nephron, is directly targeted to the apical domain when expressed in Madrin-Darbey kidney cells. J Biol Chem 1991;266:19826-32.
156. Milhiet PE, Giocondi MC, Crine P, Garbay-Jaureguiberry C, LeGrimellec C, Roques BP. Fate of a fluorescent inhibitor of endopeptidase-24.11 using enzyme-transfected MDCK cells. Monoclonal antibody-induced internalization of inhibitor-enzyme complex. J Cell Biol 1993;85:304-8.
157. Pesando JM, Tomaselli KJ, Lazarus H, Schlossman SF. Distribution and modulation of a human leukemia-associated antigen (CALLA). J Immunol 1983;131:2038-45.
158. Stefano GB, Paemen LR, Hughes TK. Autoimmunoregulation: differential modulation of CD10/neutral endopeptidase 24.11 by tumor necrosis factor and neuropeptides. J Neuroimmunol 1992;41:9-14.
159. Mattox W, Ryner L, Baker BS. Autoregulation and multifunctionality among trans-acting factors that regulate alternative pre-mRNA processing. J Biol Chem 1992;267:19023-6.
160. Llorens CB, Schwartz JC. Enkephalinase activity in rat peripheral organs. Eur J Pharmacol 1981;69:113-16.
161. Gee NS, Bowes MA, Buck P, Kenny AJ. An immuno-radiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. Biochem J 1985;228:119-26.
162. Bowes MA, Kenny AJ. Endopeptidase-24.11 in pig lymph nodes: purification and immunocytochemical localization in reticular cells. Biochem J 1986;236:801-10.
163. Matsas R, Kenny AJ, Turner AJ. An immunohistochemical study of endopeptidase-24.11 (enkephalinase) in pig nervous system. Neuroscience 1986;18:991-1012.
164. Ronco P, Pollard H, Galceran M, Delauche M, Schwartz, JC, Verroust P. Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody. Lab Invest 1988;58:210-17.
165. Sales N, Dutriez I, Maziere B, Ottaviani M, Roques BP. Neutral endopeptidase-24.11 in rat peripheral tissues: comparative localization by "ex vivo" and "in vitro" autoradiography. Regul Pept 1991;33:209-22.
166. Dutriez I, Sales N, Fournié-Zaluski MC, Roques BP. Preand post-natal ontogeny of neutral endopeptidase-24.11 ("enkephalinase") studied by in vitro autoradiography in the rat. Experientia 1992;48:290-300.
167. 125I] RB104, a new potent inhibitor of neutral endopeptidase-24.11, and its use in detecting nanogram quantities of the enzyme by "inhibitor gel electrophoresis". Proc Natl Acad Sci U S A 1992;89:6388-92.
168. Kanazawa M, Casley DJ, Sybertz EJ, Haslanger MF, Johnston CI. Localization and characterization of neutral melalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor. J Pharmacol Exp Ther 1992;261:1231-7.
169. Llorens-Cortes C, Huang H, Vicart P, Gasc JM, Paulin D, Corvol P. Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origin. J Biol Chem 1992;267:14012-18.
170. Florentin D, Sassi A, Roques BP. A highly sensitive fluorometric assay for "enkephalinase", a neutral metalloendopeptidase that releases lyrosine-glycine-glycine from enkephalins. Anal Biochem 1984;141:62-9.
171. Gafford JT, Skidgel RA, Erdös EG, Hersh LB. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 1983;22:3265-71.
172. Kenny AJ, Bowes MA, Gee NS, Matsas R. Endopeptidase-24.11: a cell-surface enzyme for metabolizing regulatory peptides. Biochem Soc Trans 1985;13:293-5.
173. Schwartz JC, Malfroy B, De La Baume SD. Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase. Life Sci 1981;29:1715-40).
174. Danielsen EM, Vyas JP, Kenny AJ. A neutral endopeptidase in the microvillar membrane of pig intestine. Biochem J 1980;191:645-8.
175. Djokic TD, Sekizawa K, Borson DB, Nadel JA. Neutral endopeptidase inhibitors potentiate substance P-induced contraction in gut smooth muscle. Am J Physiol 1989;256(Gastrointest Liver Physiol 19):G39-43.
176. Sekizawa K, Tamaoki J, Graf PD, Basbaum CB, Borson DB, Nadel JA. Enkephalinase inhibitor potentiates mammalian lachykinin-induced contraction in
177. Baraniuk JN, Mak J, Letarte M, Davies R, Twort C, Barnes PJ. Neutral endopeptidase mRNA expression. Am Rev Respir Dis 1991;143:A40.
178. Nadel JA. Regulation of neurogenic inflammation by neutral endopeptidase. Am Rev Respir Dis 1992:145(2 Pt 2):S48-52.
179. Johnson AR, Ashton J, Schulz WW, Erdös EG. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 1985;132:564-8.
180. Baraniuk JN, Ohkubo K, Kwon OJ, et al. Localization of neutral endopeptidase mRNA in human nasal mucosa. J Appl Physiol 1993;74:272-9.
181. Niehus J, Schnellbacher T, Müller S, de Baey C, Mir-Salim P, Kunkel G. Neutral endopeptidase (NEP) 3.4.24.11 in human nasal mucosa - an immunohistological study. Allergy Clin Immunol News 1994;6:85-8.
182. Borson DB. Roles of neutral endopeptidase in airways. Am J Physiol 1991;260(Lung Cell Mol Physiol 4):L212-25.
183. King KA, Hua J, Torday JS, et al. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides. J Clin Invest 1993;91:1969-73.
184. Erdös EG, Skidgel RA. The angiotensin I converting enzyme. Lab Invest 1987;56:345-8.
185. Erdös EG. Multiple functions of human "converting enzyme" and "enkephalinase" in peptide metabolism. Jpn J Hypertens 1984;6:71-80.
186. Caldwell PRB, Seegal BC, Hsu KC, Das M, Soffer RL. Angiotensin-converting enzyme: vascular endothelial localization. Science 1976;191:1050-1.
187. Braun MP, Martin PJ, Ledbetter JA, Hansen JA. Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens. Blood 1983;61:718-25.
188. Erdös EG, Schulz WW, Gafford JT, Defendini R. Neutral metalloendopeptidase in human male genital tract. Comparison to angiotensin I converting enzyme. Lab Invest 1985;52:437-47.
189. Waksman G, Hamel E, Delay-Goyet P, Roques BP. Neuronal localization of the neutral endopeptidase "enkephalinase" in rat brain revealed by lesions and autoradiography. EMBO J 1986;5:3163-6.
190. Waksman G, Hamel E, Fournié-Zaluski MC, Roques BP. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of μ- and δ-opioid receptors in rat brain. Proc Natl Acad Sci U S A 1986;83:1523-7.
191. Schwartz JC, Costentin J, Lecomte JM. Pharmacology of enkephalinase inhibitors. Trends Pharmacol Sci 1985;6: 472-6.
192. Dickenson AH, Sullivan AF, Feeney C, Fournié-Zaluski MC, Roques BP. Evidence that endogenous enkephalins produce δ-receptor mediated neuronal inhibitions in rat dorsal horn. Neurosci Lett 1986;72:179-82.
193. Roques BP. New methodological approaches for the visualisation of neuropeptidergic targets and for non-invasive investigation of grafts in the brain. In: Ottoson D, Rostene W, editors. Wenner-Green International, symposium series. Vol. 53. London: Macmillan, 1989:307-18.
194. Zajac JM, Delay-Goyet P, Meschanski M, et al. Protides of the biological fluids. Distribution in the brain and spinal cord (rat and human) of enkephalin targets (μ, δ) opioid receptors and enkephalinase in various physiopathological conditions. Vol. 35. New York: Pergamon Press, 1987:157-60.
195. Dickenson AH, Sullivan AF, Knox R, Zajac JM, Roques BP. Opioid receptor subtypes in the rat spinal cord: electrophysiological studies with μ and δ opioid receptor agonists in the control of nociception. Brain Res 1987;413:36-44.
196. 3H] HACBO-Gly to the rat brain neutral endopeptide "enkephalinase". Biochem Biophys Res Commun 1985;131:262-8.
197. Pollard M, Bouthenet ML, Moreau J, et al. Detailed immunoautoradiographic mapping system comparison with enkephalins and SP. Neuroscience 1989;30:339-76.
198. Barnes K, Kenny AJ. Endopeptidase-24.11 in the adenohypophysis of the pig is localized in the gonadotrophic cells. Peptides 1988;9:55-63.
199. Marcel D, Pollard H, Verroust P, Schwartz JC, Beaudet A. Electron microscopic localization of immunoreactive enkephalinase (EC 3.4.24.11) in the neostriatum of the rat. J Neurosci 1990;10:2804-17.
200. Delay-Goyet P, Zajac JM, Javoy-Agid F, Agid Y, Roques BP. Regional distribution of μ, δ and κ opioid receptors in human brain from controls and Parkinsonian subjects. Brain Res 1987;414:8-14.
201. Mailleux P, Przedborski S, Beaumont A, et al. Neurotensin high affinity binding sites and endopeptidase-24.11 are present respectively in the meningothelial and in the fibroblastic components of human meningiomas. Peptides 1990;11:1245-53.
202. Monod L, Diserens AC, Jongeneel CV, et al. Human glioma cell lines expressing the common acute lymphoblastic leukemia antigen (CALLA) have neutral endopeptidase activity. Int J Cancer 1989;44:948-51.
203. Iwamoto I, Ueki IF, Borson DB, Nadel JA. Neutral endopeptidase modulates tachykinin-induced increase in vascular permeability in guinea-pig skin. Int Arch Allergy Appl Immunol 1989;88:288-93.
204. Mikuni-Takagari Y, Cheng YS. Metalloproteinases in endochondral bone formation: appearance of tissue inhibitor-resistant metalloproteinases. Biochem Biophys Res Commun 1987;259:576-88.
205. Keating A, Whalen CK, Singer JW. Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation. Br J Haematol 1983;55:623-8.
206. Mari B, Checler F, Ponzio G, et al. Jurkat T cells express a functional neutral endopeptidase activity (CALLA) involved in T cell activation. EMBO J 1992;11:3875-85.
207. Painter RG, Dukes R, Sullivan J, Carter R, Erdös EG, Johnson AR. Function of neutral endopeptidase on the cell membrane of human neutrophils. J Biol Chem 1988;263:9456-61.
208. Soleilhac JM, Lucas E, Beaumont A, et al. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. Mol Pharmacol 1992;41:609-14.
209. Ardaillou N, Lelongt B, Turner N, et al. Characterization of a simian virus 40-transformed human podocyte cell line producing type IV collagen and exhibiting polarized response to atrial natriuretic peptide. J Cell Physiol 1992;152:599-616.
210. Tamburini PP, Koehn JA, Gilligan JP. et al. Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide. J Pharmacol Exp Ther 1989;251:956-61.
211. Spillantini MG, Sicuteri F, Salmon S, Malfroy B. Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid. Biochem Pharmacol 1990;39:1353-6.
212. Appelboom T, Maertelaer VD, Prez ED, Hauzeur J. Deschodt-Lanckman M. Enkephalinase: a physiologic neuroimmunomodulator detected in the synovial fluid. Arthritis Rheum 1991;34:1048-51.
213. Deschodt-Lanckman M, Michaux F, De Prez E, Abramowicz D, van Herweghem JL, Goldman M. Increased serum levels of endopeptidase 24.11 ("enkephalinase") in patients with end-stage renal failure. Life Sci 1989;45: 133-41.
214. Jancsó N. Role of the nerve terminals in inflammatory reactions. Bull Millard Fillmore Hosp 1960;7:53-77.
215. Jancsó N, Jancsó-Gábor A, Szolcsányi J. The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat. Br J Pharmacol Chemother 1968;33:32-41.
216. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:113-26.
217. Raphael GD, Baraniuk JN, Kaliner MA. How and why the nose runs. J Allergy Clin Immunol 1991;87: 457-67.
218. Lundberg JM, Hökfelt T, Martling CR, Saria A, Cuello S. Substance P immunoreactive sensory nerves in the lower respiratory tract of various animals including man. Cell Tissue Res 1984;235:251-61.
219. Nadel JA. Neutral endopeptidase modulation of neurogenic inflammation in airways. Eur Respir J 1990;3:645S-51.
220. Joos GF, Pauwels RA. The bronchoconstrictor effect of sensory neuropeptides in man. Ann N Y Acad Sci 1991;629:371-82.
221. Lundberg JM, Martling CR, Saria A. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand 1983;119:49-53.
222. Barnes PJ. Asthma as an axon reflex. Lancet 1986;1: 242-5.
223. Pick R Jr, Metzger WJ, Richerson HB, et al. Increased bronchovascular permeability after allergen exposure in sensitive asthmatics. J Appl Physiol 1987;63:1147-55.
224. McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol 1994;266:L61-83.
225. Iwamoto I, Yamazaki H, Nakagawa N, Kimura A, Tomioka H, Yoshida S. Differential effects of two C-terminal peptides of substance P on human neutrophils. Neuropeptides 1990;16:103-7.
226. Barnes PJ. Neuropeptides and airway smooth muscle. Pharmacol Ther 1988;36:119-29.
227. Nadel JA. Secreted mucosal mediators in airway epithelium. Monogr Allergy 1988;24:91-5.
228. Johnson AR, Ashton J, Schulz WW, Erdös EG. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 1985;132:564-8.
229. Couraud J-Y, Escher E, Regoli D, Imhof V, Rossignol B, Pradelles P. Anti-substance P anti-idiotypic antibodies: characterization and biological activities. J Biol Chem 1985;260:9461-9.
230. Borson DB, Malfroy B, Gold M, Ramachandran J, Nadel JA. Tachykinins inhibit enkephalinase activity from tracheas and lungs of ferrets. Physiologist 1986;29:174.
231. Sekizawa K, Tamaoki J, Graf PD, Basbaum CB, Borson DB, Nadel JA. Enkephalinase inhibitor potentiates mammalian tachykinin-induced contraction in ferret trachea. J Pharmacol Exp Ther 1987;243:1211-17.
232. Honda I, Kohrogi H, Yamaguchi T, Ando M, Araki S. Enkephalinase inhibitor potentiates substance P- and capsaicin-induced bronchial smooth muscle contractions in humans. Am Rev Respir Dis 1991;143:1416-18.
233. Crimi N, Polosa R, Pulvirenti G, et al. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma. Thorax 1995;50:505-10.
234. de Gouw HW, Diamant Z, Kuijpers EA, Sont JK, Sterk PJ. Role of neutral endopeptidase in exercise-induced bronchoconstriction in asthmatic subjects. J Appl Physiol 1996;81:673-78.
235. Lei YH, Barnes PJ, Rogers DF. Involvement of hydroxyl radicals in neurogenic airway plasma exudation and bronchoconstriction in guinea-pigs in vivo. Br J Pharmacol 1996;117:449-54.
236. Dusser DJ, Djokic TD, Borson DB, Nadel JA. Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea-pig. Possible role of free radicals. J Clin Invest 1989;84:900-6.
237. Kuo HP, Lu LC. Sensory neuropeptides modulate cigarette smoke-induced decrease in neutral endopeptidase activity in guinea pig airways. Life Sci 1995;57:2187-96.
238. Fujii K, Kohrogi H, Iwagoe H, et al. Evidence that PGF2 alpha induced contraction of isolated guinea pig bronchi is mediated in part by release of tachykinins. J Appl Physiol 1995;79:1411-18.
239. Jacoby DB, Tamaoki J, Borson DB, Nadel JA. Influenza infection increases airway smooth muscle responsiveness to substance P in ferrets by decreasing enkephalinase. J Appl Physiol 1988;64:2653-8.
240. Borson DB, Brokaw JJ, Sekizawa K, McDonald DM, Nadel JA. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 1989;66:2653-8.
241. Dusser DJ, Jacoby DB, Djokic TD, Rubinstein I, Borson DB, Nadel JA. Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. J Appl Physiol 1989;67:1504-11.
242. Piedimonte G, McDonald DM, Nadel JA. Neutral endopeptidase and kininase II mediate glucocorticoid inhibition of neurogenic inflammation in the rat trachea. J Clin Invest 1991;88:40-4.
243. Brokaw JJ, Werner LM, Miller R, White GW. Effect of dexamethasone treatment on the regional distribution of neutral endopeptidase activity in the rat trachea. Neuropeptides 1989;29:273-80.
244. Sont JK, van Krieken JH, van Klink HC, et al. Enhanced expression of neutral endopeptidase (NEP) in airway epithelium in biopsies from steroid-versus nonsteroid-treated patients with atopic asthma. Am J Cell Mol Biol 1997;16:549-56.
245. Angus RM, Millar EA, Chalmers GW, Thomson NC. Effect of inhaled atrial natriuretic peptide and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction. Am J Respir Crit Care Med 1995;151:2003-5.
246. Angus RM, Millar EA, Chalmers GW, Thomson NC. Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptides (ANP). Thorax 1996;51:71-4.
247. Harrison NK, Dawes KE, Kwon OJ, Barnes PJ, Laurent GJ, Chung KF. Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am J Physiol 1995;268:L278-83.
248. Weber S, Zuckerman JE, Bostwick DG, Bensch KG, Sikic BI, Raffin TA. Gastrin releasing peptide in a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest 1985;75:306-9.